Caption Management, LLC Viridian Therapeutics, Inc.\De Put Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$12.16 - $23.33 $1.35 Million - $2.58 Million	110,700 Added 111.03%	210,400 $4.79 Million
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.26 $3,480 - $5,178	-300 Reduced 0.3%	99,700 $1.3 Million
Q1 2024 May 15, 2024	BUY	$17.09 - $23.82 $1.71 Million - $2.38 Million	100,000 New	100,000 $1.75 Million
Q2 2023 Aug 14, 2023	BUY	$22.57 - $29.67 $677,100 - $890,100	30,000 Added 100.0%	60,000 $1.43 Million
Q1 2023 May 15, 2023	BUY	$25.04 - $37.6 $751,200 - $1.13 Million	30,000 New	30,000 $763,000

178

76.6M

581K

439K

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $770M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.